WHAT’S NEW

Filed Under News, What's New 

World Orphan Drug Congress

 

Target Health has extensive experience in Orphan and Rare Diseases including FDA approvals and multiple Orphan Drug Designations.

 

For those attending the World Orphan Drug Congress, April 25-27 at the Gaylord National Harbor Hotel in Oxon Hill, MD, please reach out to Warren Pearlson, Target’s Director of Business Development who will be attending. Warren can meet with you to discuss our Regulatory Strategy and Services in the Orphan space, and delineate how our Full-Service eCRO, supported by Target Health’s paperless eSource EDC software platform, enables efficient and cost-effective Clinical Trials.

 

For more information about Target Health contact Warren Pearlson (212-681-2100 ext. 165). For additional information about software tools for paperless clinical trials, please also feel free to contact Dr. Jules T. Mitchel. The Target Health software tools are designed to partner with both CROs and Sponsors. Please visit the Target Health Website.

 

Joyce Hays, Founder and Editor in Chief of On Target

Jules Mitchel, Editor

 

Comments

Leave a Reply

You must be logged in to post a comment.